ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000625.1|Thioviridamide_1 # 2 # 193 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.729	BGC0000625.1|Thioviridamide_1 	2	193	+	Loose	550	24.6386	vgbC	33.33	3003990	protein homolog model	n/a	n/a	streptogramin antibiotic; streptogramin B antibiotic	antibiotic inactivation	streptogramin vgb lyase	ACCCCGTCGGCCGCCCGGCAGCCGTACCGGTCCCACGGGAGACGTTCCGTCCCTCGTGGCCGGACCGGCCGCCGGCTCCGACGGATCGTCACCGCAGCGTCGCGAAACGAACGCCCCGGCATCGCTTTGGTGTCGGGGCGGTCGCGCATCCGGACGGCCGAGGTGTGGTGTCAGTGGCTGCGGATAGGCTGA	TPSAARQPYRSHGRRSVPRGRTGRRLRRIVTAASRNERPGIALVSGRSRIRTAEVWCQWLRIG	MQIAAQEYKTANRESGPYGITARQDRTIWFTEQKGNRIGRLTKDGDMRTFEVPTPDAGVMSILSAHTGDLWFTEYKANKIGRMTMEGTFAEFELPEANSSPYGLAEGPDGAIWFTELSGNRIGRITPAGIITEYDLPCEGSYPSYITAGPDGALWFTENQNNCIGRITVDGEITEYRIPTEQSGPVGITTGADGALWFVQINGNQIGRITTAGEITEFKLPSGNARPHAITAGVSGDLWFTEWGANQIGRITCTGDITEYPIPTPSAEPHGITVDSGGEVWFAEECDQIGRFTIQY	21.28	gnl|BL_ORD_ID|2244|hsp_num:0	2526			9	156	pristinamycin IA; quinupristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3
BGC0000625.1|Thioviridamide_2 # 198 # 3509 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.760	BGC0000625.1|Thioviridamide_2 	198	3509	+	Loose	1050	32.3426	lmrC	29.41	3002881	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGACGCGAGCCGAGCAGCCAACGGCCCCCACCCCAGCACCGGACGACGCCCTCGTCGCGGACTCCCGCGAGCGTGCCGTCCGTTCCCTGCTGCGCCGACCGGAGCTGCGGCGCCTGTGGAGCGCCCAGCTCGTGAGCGGTGTCGGCGACACCCTCGCGGTCCTGGTGCTGGTCGTCCTCGCCCTCCAGGCAGCCATCGCGGAGGGCTCCTTCGGCGGTGGATACCGCGGCGTCGCGTTCGCGGTGGCGACCGTCTTCGCGGCCCGCATCCTCGCCACGCTGCTCTTCGGGGCCGTCCTCCTCGGCCCGCTCAGCGCGCTGACCGACAAGGAAGGCCCGCTGGACCGCCGCTGGACCATGGTCGGCGCCGACGGTCTGCGTGCCGTACTGCTGATCATCGCGCCCCTCTGGATCGACTGGACGCCGCAGAACGCGCTGGCGTATCTGCTCGTCACCGCCTTCGTCACCGGAGTCGCCGAGCGCCTGTGGACGGTGTGCCGGGAGAGCGCGGCCCCCGCGCTGCTGCCCGCCCCGCCCCCGGAGGGAGCGACCGTACGGCCGCTGCCGGACCACATGGACGCCCTGCGCCGCCTGGCGCTGCGCACCACGTTCCTGGCGATCCCGCTCGCGGCCGCCGCGCTCGTCGTCGCCGCGCTCTTCAACAACCTGCTCGGGACCGGTGTCGACTGGTTCGACCAGCACCAGGCGGCCCTCGGGTCGTACGTGGCGGCCGGTCTGTTCGCCGCCTCCCTGTCGGTGCTGACCGCCCTGGAGCTGCCCGGCATCCGCACCCCACGCGCGCGGTCCCCGCTGGAGGGCCTGCGCCGCCCGCGCACCGGCGCCGGTGTGGACAAGGGCCGTACGGGCGCCATCCCGCTGCTCGTCCCGGCCTGCGCCGCCGTCGCCGGGGCCATCTCCGCCGCCGTCTCCGTGTGCGTGCTGCACGCCAAGGACCTGGGCGGCGGCCCGGTCCTGTACGGCCTGCTGGTCCTCGCGCTGACCGGCGGCGTCGCCGTCGGCATCCGTACGGCGCCCTCGATGCTGCCCTCGCTCTCGCGCCGCCGGCTGCTGGCCCTGGCGATCGCCTTCACCGGCGTCGCCCTGCTGGCCGCGGGCCTCGTCCCCGACGTCACCACGGTCCTGCTGATCGTCGCGCTGGCCGGCATCGGCGCGGGCGTGGCCGCAAACACCGGGCACACCCTGCTCGATCAGGAGACCGAGGACCACCGCAGGGCGCGCACCACCGAGCACCTGCACGCGGTGGTCCGCGTCTTCATAGCGCTCGGCGTCCTGATCGCGCCCCTGGTCGCGGCCCTCATCGGCCCGCACCGCCTGGAGAACGGCAAATTCGTCTTCGCGCACGGCGGAGCCGCGTTCACCCTGATGCTGGTCGGCGCGCTGCTGCTGCCGGTCGCCGCGCTGGTCCTCGCCAAGGTCGACGACCGCTCCGGCGTCCCGCTGCGGCACGACCTCAGGGACGCGCTGCTCGGCGGCGACGACCCCGTCCAGGCCCCCGCGTCGAACGGTTTCTTCATCGCCCTGGAGGGCGGTGACGGCGCCGGCAAGTCCACCCAGGCCGAAGCACTCGCCGAGTGGATCCGGGCCAAGGGCCACGAGGTCGTCCTCACCCGGGAGCCGGGTGCCACCCCGGTCGGCAAGCGGCTGCGCTCGATCCTGCTGGACGTGTCCTCCGCCGGCCTGTCCCACCGCGCGGAGGCCCTGCTCTACGCCGCCGACCGGGCCGAGCACGTCGACACCGTCGTCCGGCCCGCCCTGGAGCGCGGCGCGATCGTCATCTCGGACCGGTACATCGACTCCTCCGTCGCCTACCAGGGCGCCGGCCGCGATTTGTCCCCGACGGAGATCGCCCGGATCAACCGCTGGGCGACCGACGGGCTCGTCCCCCACCTCACCGTCCTGCTGGACGTCGCGCCGGAGGCCGCCCGCGAGCGGTTCACCGAGGCGCCGGACCGGCTGGAGTCGGAGCCGGCCGAGTTCCACGCGCGCGTGCGGTCCGGTTTCCTCACCCTCGCCGCGTCCGACCCCGGCCGCTACCTGGTCGTGGACGCCGCGCAGGAACCCGAAGCCGTCACCACGGTGATCCGGCACCGGCTCGACACCGTCCTGCCGCTCTCCGAGGCCGAGATCAAGGCCCAGGAGGAGGCGCGCAAGCGGGCCGAGGAAGAGGCCCGCCGCAAGGCCGAGGAAGAGGCCGCCCGCAAGGCCGAGGAGGAGCGCCTGGAGCGCGAGCGCCAGGAGCAGCTCGCCAAGCTGCGCGCCGAGGAGGAGGAGCGCAAGCGCCGCGAACTGGAGGAGGCGCAGCGCCGGGAGGCCGAGCGGCAGGCGGAGGAGGCCCGGCAGCGCGCCGAGGAAGCGCGCCGCCGTGCCGAGGAGGAGCAGCAGCGGCTCCTCGCCGAGGAGAAGGCCCGCGCCGAGGAGGAGGCCCGCCGCAAGGCCGAGGAGGAACGGCGCCGCAAGCAGGCCGAGGAGGAGGCCCGGCTGCACGCCGAGGCCGAGGCCCGGCGCCTGGAGAAGCAGCGCAAGGCCGAGGAGGCTTTGCTGCGCGCCGAGGAGGCCCGCCGCCAGGCGGCCGAGGCCGCCGCCTCGGCCGACGCGGCGGCCCGCCGGCCCGCGGCACCGCAGCCCAAGGCCCCCGGGATGCCCCCGGAGGCGGCGGCGACGGTCCCGACACCGGCCGTGTCCCCGGCCGACCCGCAGAACCAGCGGCGGACCGCCGCACCGGCGCCGGGCGCCGAGGAGACGGTCCCGACACCGGTCGTCTCCCCGCCCACGGACGAGACGACGGTGCTGCGCCCCGTACGCGAGGACCGCCCCGCGGACGCCTCCCACCCCGACTCCGAGGTGACCACCGAGCTGCCGCAGCCGCCGGCGACCCCGGGCGCGGCGGACGACACGGCGGTGCTCCCACCGGTGGCTCCCGGCGCGGCCGACGAGACCGCCGTACTGCCTCCGGTGCCCCCGGGGGCGGCCGACGAGACGGACGTACTCCCGCCCGTGCGGGACCGTGACCCGGCGGACCGGGTGCCGCCCGGCCTGTTCCGGGACGAGCGGGCCGCCTCCGGCCCCGACGGTTCCGAGAGCCGTACCCGCGAGATGCCCCAGCTCGACGCGGACGGCACCCCCCGGCGCCGGCCGCGCCCCGACTGGGCCGAGGAGACCCCGCTGGACGACCTGCCGAGCCTGGCGGACGAACTCCTCGGTTCGTACGACTCCTACGACTCGCACGACGAGCAGGTGCACGGGGACGTCGAGGAGGACAAGGGCCGACGCGGACGGGGCCGCCGGGGCTGA	MTRAEQPTAPTPAPDDALVADSRERAVRSLLRRPELRRLWSAQLVSGVGDTLAVLVLVVLALQAAIAEGSFGGGYRGVAFAVATVFAARILATLLFGAVLLGPLSALTDKEGPLDRRWTMVGADGLRAVLLIIAPLWIDWTPQNALAYLLVTAFVTGVAERLWTVCRESAAPALLPAPPPEGATVRPLPDHMDALRRLALRTTFLAIPLAAAALVVAALFNNLLGTGVDWFDQHQAALGSYVAAGLFAASLSVLTALELPGIRTPRARSPLEGLRRPRTGAGVDKGRTGAIPLLVPACAAVAGAISAAVSVCVLHAKDLGGGPVLYGLLVLALTGGVAVGIRTAPSMLPSLSRRRLLALAIAFTGVALLAAGLVPDVTTVLLIVALAGIGAGVAANTGHTLLDQETEDHRRARTTEHLHAVVRVFIALGVLIAPLVAALIGPHRLENGKFVFAHGGAAFTLMLVGALLLPVAALVLAKVDDRSGVPLRHDLRDALLGGDDPVQAPASNGFFIALEGGDGAGKSTQAEALAEWIRAKGHEVVLTREPGATPVGKRLRSILLDVSSAGLSHRAEALLYAADRAEHVDTVVRPALERGAIVISDRYIDSSVAYQGAGRDLSPTEIARINRWATDGLVPHLTVLLDVAPEAARERFTEAPDRLESEPAEFHARVRSGFLTLAASDPGRYLVVDAAQEPEAVTTVIRHRLDTVLPLSEAEIKAQEEARKRAEEEARRKAEEEAARKAEEERLERERQEQLAKLRAEEEERKRRELEEAQRREAERQAEEARQRAEEARRRAEEEQQRLLAEEKARAEEEARRKAEEERRRKQAEEEARLHAEAEARRLEKQRKAEEALLRAEEARRQAAEAAASADAAARRPAAPQPKAPGMPPEAAATVPTPAVSPADPQNQRRTAAPAPGAEETVPTPVVSPPTDETTVLRPVREDRPADASHPDSEVTTELPQPPATPGAADDTAVLPPVAPGAADETAVLPPVPPGAADETDVLPPVRDRDPADRVPPGLFRDERAASGPDGSESRTREMPQLDADGTPRRRPRPDWAEETPLDDLPSLADELLGSYDSYDSHDEQVHGDVEEDKGRRGRGRRG	MADASIVCTNLSFSWPDETPVFDGLSFALGAGRCGLVGPNGAGKSTLLRLAVGELTPTAGSITAQGHVGYLPQSLPLIDGTVDEALEIASIRAALHAIESGDVDEAHFTTVGDHWDIEERTTIVLDRLGLGDVSLDRPLRSLSGGQVLAIGLAAQLLKRPDVLILDEPTNNLDLAARQRLYQVVEEWKGALLVVSHDRELLDRVDTIAELQASELRLYGGNFTAYTEAVELEQENVQRAVRGAEQELRRHKREAQAAQERAQRRASNAKRNKASSGVPRIHAGALQRQAQESAGRAASVHQDRVSQAKAKLDEASQGMREEARLAITLPQTSVPAGRTVLTCHEANVRYGERTLFTGSGVDLGIRGPERIALLGPNGSGKSTLLKLIAGELEPSSGTVTAPTDRVSYLSQRLDLLDLDASVLDNLRRFAPHLQDGEVRYRLAQFLFRGDRVHRTAGWLSGGERLRATLACVLSTDPAPQLLLLDEPTNNLDLNSAAQLENALNAFQGAFVVVSHDQAFLRAIGVSRWLRLADGTLEEIAEADDAWPHRDK	200.55	gnl|BL_ORD_ID|900|hsp_num:0	974			687	996	lincomycin; clindamycin; celesticetin
BGC0000625.1|Thioviridamide_3 # 3664 # 4869 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.747	BGC0000625.1|Thioviridamide_3 	3664	4869	+	Loose	600	27.7202	CfxA6	40.0	3003097	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CfxA beta-lactamase	ATGACCGTGTGGGACGACCTCGTCGGGCAGGAGAAGGTGAGCGCGGCGCTCGACGCCGCCGCGCGGGACGCCGACGCCCTCGTCACGGCCGCAGCGGCGGACCAACCGCTGCCGGGGTCGTCGAAGATGACGCACGCCTGGCTGTTCACCGGCCCGCCCGGAGCCGGCCGTAACCAGGCGGCGCGGGCCTTCGCCGCCGCCCTGCAGTGCGTCAGCCCCGACCGTGCCCTCGGCGGAACCCCCGGCTGCGGCTTCTGCGACGGCTGCCACACCGCGCTGCTCGGCACCCACGCGGATGTCACCACGGTCGCCGCCGTCGGCTCCGAGGTCCTGGTGAAGGACATGCGGGACACCGTCCGCAAGTCGTTCACCGCCCCGGCGAACGGCCGCTGGCAGACCATCCTCGTCGAGGACGCCGAGCGGCTGAACGAGAAGTCGGCCAACGCCGTCCTCAAAGCGGTGGAGGAGCCCGCGCCCCGCACGGTGTGGCTGCTGTGCGCCCCCTCGATCGAGGACGTCCTGCCGACCATCCGCTCCCGCTGCCGCCACCTGAACCTCAGCACCCCGTCCGTCGCCGCGGTCGCCGACATGCTCGTACGGCGCGACGGCGTCGAACCGGACGTCGCCGCCGAGGCAGCCCGCGCCACCCAGGGGCACGTCGACCGGGCGCGCCGCCTGGCCACGGACCCCGCGGCCCGCGGGCGCCGCGCGGCCGTCCTCAAGCTCCCGCTGCGCCTCGACGAGGTCGGTGCCTGCCTCAAGGCCGCGCAGGAACTCGTCGACGCGGCCGCCGAGGACGCCAAGCAGCTCGCCGAGGAGATGGACGGCAAGGAGGCCGAGGAACTCAAGGCGGCGCTGGGCGCGGCCCAGGGCGGGCGGCTGCCGCGCGGCACCGCGGGGGTGATGAAGGACCTGGAGGACATGCAGAAGCGCCGCAGAACCCGTACGCAGCGCGACAGTCTGGACGTGGCCCTCGGTGATCTCACCGCCTTCTACCGGGACGTGCTCGCCCTCCAGCTCGGCTCGCGCGTCGCCATCGCCAACGCGGACGCGGAGGACGCGCTGGAGCGCCTGGCCCGCTCCGGATCGCCCGAGTCCACCCTGCGCCGCATCGAGGCGATCGCCGCGTGCCGGGACGCCCTGGACCGCAACGTGGCTCCGCTGCTCGCGGTGGAGGCGATGACGATGGCGCTGCGGGCCGGCTGA	MTVWDDLVGQEKVSAALDAAARDADALVTAAAADQPLPGSSKMTHAWLFTGPPGAGRNQAARAFAAALQCVSPDRALGGTPGCGFCDGCHTALLGTHADVTTVAAVGSEVLVKDMRDTVRKSFTAPANGRWQTILVEDAERLNEKSANAVLKAVEEPAPRTVWLLCAPSIEDVLPTIRSRCRHLNLSTPSVAAVADMLVRRDGVEPDVAAEAARATQGHVDRARRLATDPAARGRRAAVLKLPLRLDEVGACLKAAQELVDAAAEDAKQLAEEMDGKEAEELKAALGAAQGGRLPRGTAGVMKDLEDMQKRRRTRTQRDSLDVALGDLTAFYRDVLALQLGSRVAIANADAEDALERLARSGSPESTLRRIEAIAACRDALDRNVAPLLAVEAMTMALRAG	MSNYSVAELRNMKKNRKKQIVVLCIALVCIFILVFSLSHKSATKGSANPPLTDVLTDSISQIVSACPGEIGVAVIINNTDTVSVNNKSIYPMMSVFKVHQALALCNDFDKKGLSLDTLVKINREKLDPKTWSPMMKDYSAPVISLTVRDLLRYTLSQSDNNASNIMFKNMLNTAQTDSFIAKLIPRSSFQIAYTEEEMSADHDKAYSNYTSPLGAAMLMNRLFTESLISNEKQDFIKNALKECKTGIDRIVAPLLDKEGVVIAHKTGSGNVNENGILAAQNDVAYICLPNKVCYTLAVFVKDFKGNESQASQFVAHISAVVYSLLINTALN	121.15	gnl|BL_ORD_ID|240|hsp_num:0	268			711	801	
BGC0000625.1|Thioviridamide_4 # 4912 # 6624 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.733	BGC0000625.1|Thioviridamide_4 	4912	6624	+	Loose	500	27.335	OXA-873	36.67	3006065	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGTGGCTTCGGGGCGGCGTCCCCCACACGGGCGTACCGGAGCGAACGCCGCCCCCGTCCCCCGAACGAGCCACAAAGCCGACGCACCGCGCTCGCGAGGTCGCACAGCGTTACGCTCGCTTGATGCAGATCAGGCCCACCCCCCGCCGCCCCCGGCCGACGGCCCGAGTCGCCGCCACCCTCCTCGCGGCCGCCGCCCTCCTCGTCTCCGCCTGTTCCCCGAGCAGTTCGACGGTGTCGGCCGGGGCCACGGCGGAGGGGGTGCTGGCGGCGCTGCCGCGTGCGACACCGCCGGCGCTGTCGCCGTACTACGAGCAGAAGCTGCACTGGCGCAGCTGCGGCGCGCCCGGCTTCCAGTGCGCGACGATGAAGGCCCCGCTGGACTATGCGAAGCCCGCCGCGGGTGACGTCCGGCTGGCCGTCGCCCGGAAGAAGGCCACGGGCAAGGGCAAGCCGCTGGGCTCGCTGCTGGTCAACCCGGGCGGTCCGGGCGGCTCGGCGGTCGGCTACCTCCAGCAGTACGCGGGCATCGGCTACCCGGCCGGGGTCCGGGCCCGCTACGACATGGTCGCGGTGGACCCGCGGGGTGTGGCCCGCAGCGAGCCGGTGGAGTGCTTCGACGGCCGCCAGATGGACACGTACACGCAGACGGACACGACCCCCGACGACCGGCGGGAGACGACCGCGCTGGTGACGGCGTACAAGAAGTTCGCGGAGAGCTGCGGGGCGCACTCGGCGCGGCTGCTGCGGCACGTCTCCACGGTCGAGGCCGCCCGGGACATGGACATCCTGCGGGCGGTCCTGGGCGACCGGAAGCTGAACTACGTGGGGGCGTCGTACGGCACGTTCCTCGGGGCGACGTACGCGGGCCTGTACCCGCAGCGGGTGGGCCGCATGGTGCTGGACGGGGCGATGGACCCCTCCCTGGACTCGCGCGAGCTGAACCTGGGCCAGACGGCGGGCTTCGAGACGGCGTTCCAGGCGTTCGCGAAGGACTGCGTACGGCACTCAGGCTGCCCGCTGGGCGGCAGGGGCACCACGCCGGCGCAGGTCGGCGACCACCTCAAGGCGTTCTTCGGCAAGCTGGACGCCCACCCCGTCCCGGCCGGCGACGCGGACGGCCGCAAGCTGGGCGAGTCGCTGGCCACGACGGGCGTGATCGCGGCGATGTACGACGAGGCCGCCTGGGAACAGTTGCGCGAGGCGCTGGCCTCGGCGATGAAAGAGAACGACGGCGCCGGCCTGCTCGCGCTCTCCGACAGCTACTACGAACGTGACGCCGACGGGCACTACACCAACCTGATGATGGCCAACGCCGCCGTGAACTGCCTGGACCTGCCGCCCGCCTTCACCGGTCCCGAGCAGGTGGAGCAGGCCCTGCCCGAGTTCGAGAAGGCGTCCCCCGTCTTCGGCGAGGGGCTGGCCTGGGCCTCGCTGAACTGCGCGTACTGGCCGGTCAGGGCCACGGGGGCGCCGCACCGCATTGAGGCGAACGGCGCGGCCCCGATCGTCGTGGTCGGCACCACCCGGGACCCGGCGACCCCCTACCCGTGGGCCCAGTCCCTGGCCCGCCAGCTCTCCTCGGCCCGCCTCCTCACCTACGTCGGCGACGGCCACACCGCCTACGGCCGCGGCAGCACCTGCATCGACGGAGCGATCAACACATACCTCCTCCACGGCACCCCGCCGGCCCCCCAGAAGCGCTGCTCATAG	MWLRGGVPHTGVPERTPPPSPERATKPTHRAREVAQRYARLMQIRPTPRRPRPTARVAATLLAAAALLVSACSPSSSTVSAGATAEGVLAALPRATPPALSPYYEQKLHWRSCGAPGFQCATMKAPLDYAKPAAGDVRLAVARKKATGKGKPLGSLLVNPGGPGGSAVGYLQQYAGIGYPAGVRARYDMVAVDPRGVARSEPVECFDGRQMDTYTQTDTTPDDRRETTALVTAYKKFAESCGAHSARLLRHVSTVEAARDMDILRAVLGDRKLNYVGASYGTFLGATYAGLYPQRVGRMVLDGAMDPSLDSRELNLGQTAGFETAFQAFAKDCVRHSGCPLGGRGTTPAQVGDHLKAFFGKLDAHPVPAGDADGRKLGESLATTGVIAAMYDEAAWEQLREALASAMKENDGAGLLALSDSYYERDADGHYTNLMMANAAVNCLDLPPAFTGPEQVEQALPEFEKASPVFGEGLAWASLNCAYWPVRATGAPHRIEANGAAPIVVVGTTRDPATPYPWAQSLARQLSSARLLTYVGDGHTAYGRGSTCIDGAINTYLLHGTPPAPQKRCS	MNIKALLLITSAIFISACSPYIVTANSNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQTQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTLGDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL	208.03	gnl|BL_ORD_ID|4100|hsp_num:0	5170			3	93	cloxacillin; oxacillin; cefalotin
BGC0000625.1|Thioviridamide_5 # 6569 # 6919 # -1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.650	BGC0000625.1|Thioviridamide_5 	6569	6919	-	Loose	500	23.483	OXA-641	69.23	3005333	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGAGACCAGAATCGAGACCAGGGACGGCCGCACGGCCCGCGCGCAACGTCGTCGCGGCATCCGCTGAACGAGTAAGCCCAGCTCAGACACTGTCTGGGCTGGGCTTAGAAAGAGCCGCCTTCGGGATTCGAACCCGAGACCTACGCATTACGAGTGCGTTGCTCTGGCCATCTGAGCTAAGGCGGCACGCCGACCGCGACTATGGTGCGATCAGCAACGTCGGTAAGTCTACACAGTTTCCGGGGGTGCTCCGTACACGCCCTCGGGGGTGGGGGAAGGCGGGGCTCGGGAGGGCTATGAGCAGCGCTTCTGGGGGGCCGGCGGGGTGCCGTGGAGGAGGTATGTGTTGA	MRPESRPGTAARPARNVVAASAERVSPAQTLSGLGLERAAFGIRTRDLRITSALLWPSELRRHADRDYGAISNVGKSTQFPGVLRTRPRGWGKAGLGRAMSSASGGPAGCRGGGMC	MKHIFLVFLILCSNFALAEDKAISAIFSTEGVDGTIILKSLRGDKTITHNDARASRRFASASTFKIFNTLIAVQENVVSLSGTAFRWDGKTHDFPDWNRDQTLESAFKVSCVWCYQEIAKQVGEETYRRYLALARYGALSNVADSTTFWLDGSFTVSAVEQVALLKKIYLRELPFRDDAYDALKRVMLAEQTDSYKLYAKTGWAGRMNPQIGWYVGYVETSDDVWFFAINLTLRSETDLGLRQQITKAVLRAERIIP	45.14	gnl|BL_ORD_ID|3040|hsp_num:0	4065			405	444	cloxacillin; oxacillin; cefalotin
BGC0000625.1|Thioviridamide_6 # 7449 # 7676 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.662	BGC0000625.1|Thioviridamide_6 	7449	7676	+	Loose	875	25.0238	mdtP	55.56	3003550	protein homolog model	n/a	n/a	nucleoside antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACGGAGAAGACTCAAATCACCGACGTTCAGGCGTTCGAGGACCTCGTGGCCAAGGTGCAGGAGATGGACGGCCCCGCGCAGGCGAGCTCCACCGTCGCGGCCCTTGCCGGTCTGGACGCGGCCGAGCTGCAGAACTTCCTCGAGGAGAAGTCCGGCATCTCCCCGGATGAGGAGGCCCAGGGCAGCGTCATGGCCGCCGCTGCGTCGATCGCTCTTCACTGCTGA	MTEKTQITDVQAFEDLVAKVQEMDGPAQASSTVAALAGLDAAELQNFLEEKSGISPDEEAQGSVMAAAASIALHC	MINRQLSRLLLCSILGSTTLISGCALVRKDSAPHQQLKPEQIKLADDIHLASSGWPQAQWWKQLNDPQLDALIQRTLSGSHTLAEAKLREEKAQSQADLLDAGSQLQVAALGMLNRQRVSANGFLSPYSMDAPALGMDGPYYTEATVGLFAGLDLDLWGVHRSAVAAAIGAHNAALAETAAVELSLATGVAQLYYSMQASYQMLDLLEQTHDVIDYAVKAHQSKVAHGLEAQVPFHGARAQILAVDKQIVAVKGQITETRESLRALIGAGASDMPEIRPVALPQVQTGIPATLSYELLARRPDLQAMRWYVQASLDQVDSARALFYPSFDIKAFFGLDSIHLHTLFKKTSRQFNFIPGLKLPLFDGGRLNANLEGTRAASNMMIERYNQSVLNAVRDVAVNGTRLQTLNDEREMQAERVEATRFTQRAAEAAYQRGLTSRLQATEARLPVLAEEMSLLMLDSRRVIQSIQLMKSLGGGYQAGPVVEKK	15.37	gnl|BL_ORD_ID|36|hsp_num:0	45			408	462	acriflavine; puromycin
BGC0000625.1|Thioviridamide_7 # 7736 # 8065 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.624	BGC0000625.1|Thioviridamide_7 	7736	8065	+	Loose	920	26.5646	OpmD	46.67	3000809	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCTGCCGCGGTGCGGTGCTCCGCACGTCCAGCGGTCCCGCTGCGTTTCTGACCATGACGTGTCCCGATTCGAAGGCAGGAACTTTGACGAGACCACCCGGGATGCCGAACCCGGGATTCGGAGCCCGAGGGCAGCCCTTGACGCGATATGGGTCGACGCCTTGCCGGTCAACCACTGGCCGAATCCATACAGTCCAGCTCCCTCTTACCGATTTTCATCCGTGATCTGCTGGCAACAATCCAGCTGCCTTGATACGGTCACGACGGTTGGCACACAGAGCTCGCGCTGCAACTGCAGCCCGGTTCGGACTCGGGGGAGATGCCGCTAA	MLPRCGAPHVQRSRCVSDHDVSRFEGRNFDETTRDAEPGIRSPRAALDAIWVDALPVNHWPNPYSPAPSYRFSSVICWQQSSCLDTVTTVGTQSSRCNCSPVRTRGRCR	MKRSYPNLSRLALALAVGTGLAACSVGPDYQRPQSPPPRVASEHLGEFSGERREAPWWSFFDDPQLVRLVDQALARNHDIREARANLRSARALFDDRWLDQLPQVTSQAGYSRSIEQQLDYDGEPRRRLAESYRAGFDAQWEIDLFGRLGRLSDAALARAEAADADLRLVRLSIAADTARAYFEIQGYQRRLDVARAQVRSWRDTLELTRSSLQLGSGLPEDVENAQANLLRSEAAIPPLTTALESARYRLDVLRGEAPGSGAPILDGGAAAPLAKNLPLGDVDRLILQRPDVVSAERQLAASTEDVGAATAELYPRLDLGGFIGFFALRSGDLGSASRAFELAPSVSWPAFRLGNVRARLRAVEAQSDAALARYQRSLLLAQEDVGNALNQLAEHQRRLVALFQSATHGANALEIANERYRAGAGSYLAVLENQRALYQIREELAQAETASFVNVIALYKALGWGSGDLAPGAGQLAAGETAGANR	22.38	gnl|BL_ORD_ID|450|hsp_num:0	442			225	309	acriflavine; tetracycline; norfloxacin
BGC0000625.1|Thioviridamide_8 # 8172 # 8402 # -1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.636	BGC0000625.1|Thioviridamide_8 	8172	8402	-	Loose	500	21.9422	APH(3')-IIc	26.67	3002646	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	GTGAATGAGCTGATCCCTGGTAAGGGACTGCCCAAGGCAACTCGCCAGCATTGCGAGGACTGTTGCCTGTCGAGGGGTCATTTCTATCTGCCGACCCTCGGCATCCAGTGTGAGCACAGACCCCAGGAGATAGACGCGGACCGGGGGCAGGACACTCGGCCCGCCAGTGGCCCCCACGATCCCGTCCAGGGAGACGGAGCGTTTCGCGATCACATCGGGATCCGGCCGTGA	MNELIPGKGLPKATRQHCEDCCLSRGHFYLPTLGIQCEHRPQEIDADRGQDTRPASGPHDPVQGDGAFRDHIGIRP	MEASNPFTDGLRLPRAWQEALADAHIERQSIGVSRADVARVHRPGQTDAFLKSEVIDAFSELGDEIARLRWLQAQGQSAPTVIATTEEGGRRWLLMSALPGRDLASSPELAPRRVAELLADALRGLHAVPVANCPFDQQLASRLQAAQARVEAGLVDADDFDDERLGQSPQQVFAELRATRPAHEDLVVSQGDACLPNLTVTDGRFTGFIDCGRLGVADRYQDLALAARSLVHNFGESRCVAALFQRYGAVPDERRLAFYRLLDEFF	28.46	gnl|BL_ORD_ID|939|hsp_num:0	1018			12	147	neomycin; ribostamycin; butirosin; kanamycin A; gentamicin B; paromomycin; gentamicin
BGC0000625.1|Thioviridamide_9 # 8576 # 8884 # -1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.647	BGC0000625.1|Thioviridamide_9 	8576	8884	-	Loose	300	25.0238	AAC(2')-IIa	22.95	3004628	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(2')	GTGCGGCCACTGTTGTGCAGGCACGCCATCAGTCGCGCGTGGAGTCCCTGGTGTCGGGGAAAGCGTGACAGGCTGTCCCGGATCCGCTCGATGACAATCGCGGAACGCCCACAACGAATGTTCACGTCGATCCACTCCGTCAGTGTTTCGATATGCCGCTCGACGGCCTTCAGACGGAATTCATCGGCGAACGGCGCCCGAATGTCGAGCACGGGATCGTCCCGCCACAGGTCGATCGCGCGACGAAGGGCTTCGATTGCCGCTTCATCCCTGCCGGCCGACCGCGCGTCCGCGGCGATCACCCGGTAG	MRPLLCRHAISRAWSPWCRGKRDRLSRIRSMTIAERPQRMFTSIHSVSVSICRSTAFRRNSSANGARMSSTGSSRHRSIARRRASIAASSLPADRASAAITR	MKDRSHDDSMAEVCRNTSENHWLKTDYRTLFRLCPDGRIERENDPDCSPGPRFWLAGCSEGNVFGVRADVPDDIALKLEELASVEPPFTPPAIPKHLERYLSLLGSDGPVTHDLGLIYELPHAQQYPSKARLIGSGSEEGESLMQSWAEDRVPEALFELGFREVADFWTPWCAAVVDGEVASIAFAARLADAGAELGLVTAKAFRGQGFAAAATAGWSRLSALRSRTLFYSTDRDNISSQRVAARLGLRLRGASLRISRA	39.23	gnl|BL_ORD_ID|2209|hsp_num:0	3327			489	666	kasugamycin
BGC0000625.1|Thioviridamide_10 # 9262 # 10398 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.711	BGC0000625.1|Thioviridamide_10 	9262	10398	+	Loose	450	33.4982	APH(3'')-Ic	39.34	3002640	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3'')	ATGGTGAGCACCCGACGCGATGTCCTTCCCGACGCGATGTCGCACCGGCCCCGGTACTCGGTGGAACACCTGCTGCGGCGGCGCATGCACGGCATGGTCCTGCCTGGCTTCGACCGGATCGCAGGGCCGCCCGCACCGCGCGTGACGACTTACATCCACGAGGCGGCCGGTCTCGCCGTCGCCGGCCTGGGCGGCTCCCACGGCTCGTCCGTCATCTCCTGCACGCCGTGCGTGAGCCGCGGCGCCTCGGCGATCGCCGAGACCGACAGCGGTGCGCGCCTGTTCGTCAAGGCGCTGGGGCCCGGAGGGTTCGGCTACGAGAACGAAGCGGTCGTTCTCGGCCTGCTCGGGGACGCCCGGAAGTCCGGAATCCGGGTTCCGGCACCGGAGTTGCTGTTCTGGGATCCGGTCAGGCACGTGCTCGCCACGACGGAGGTGGGCCACTCGGCGTCCCTTGACGTGGTGTTGCGCACCGCGGACGCCCGAGCCGCGGCAACGGCGTCGACCCTGGTGGGACGCGCACTGGCGACGGTGCACGCGGCGCGGGTCGATGTCGGGCCACTGGCGGCGGAGGGCAGGGTCCATCCGTTTCCGCTCGACGACCTGGCGGACCTGACGCCGAGTGAGCTCAGCAGCGGGGTCGGTGTCGACTTCGACGAGTTCGTCGCATGTGTCCAGTCGGTCTCGGCGGAACTGGGGCGACTCAGGGAAGAGCGGTTCGATCCCGTCCTCGTGCACGGGGACCTGCGGGCACCGAATGTCCTGGTCGGACAGAGCCGCGACCCGGCGGAGGACGGCGCGGTCTTCGTGGACTGGGAGCTCGCATGCGTGGGTGACGTGGCCGCCGACGTCGGCACGGTCCTGGCCGAGGCCCTTGCCACGGACCTCGCGGTGCACGGCGACATCCGTACCGCCGGCCTCTGGAACAGGATCTTCCTCGACTCCTACCAGGGGCGGTCGCCCATGGACGAGGAGTCGGTGCTCCGCTCCGTCCGGTACTGCGGCACGCAGTTGATCCGCGGAACCCTCAGCAGGCTGGAGCACCAGGGGACCCTCGGACGGGTGGGACGGCTGCAACTCATCCTCGGGTCGGCGATCCTGCGCGACCCGGCGCGGTCGAAGGGGGTCGCGTGGTGA	MVSTRRDVLPDAMSHRPRYSVEHLLRRRMHGMVLPGFDRIAGPPAPRVTTYIHEAAGLAVAGLGGSHGSSVISCTPCVSRGASAIAETDSGARLFVKALGPGGFGYENEAVVLGLLGDARKSGIRVPAPELLFWDPVRHVLATTEVGHSASLDVVLRTADARAAATASTLVGRALATVHAARVDVGPLAAEGRVHPFPLDDLADLTPSELSSGVGVDFDEFVACVQSVSAELGRLREERFDPVLVHGDLRAPNVLVGQSRDPAEDGAVFVDWELACVGDVAADVGTVLAEALATDLAVHGDIRTAGLWNRIFLDSYQGRSPMDEESVLRSVRYCGTQLIRGTLSRLEHQGTLGRVGRLQLILGSAILRDPARSKGVAW	MTEWLPVTRGESGAGVFRNSDGSSYAKVVDAAAVADLAAERDRVSWAHRHGVPGPAVIDWRVTEDGGACLITSTVRGVAADRLSESALRAAWPAIVEAVRTLHALPADGCPYRRDLDDMLARARAVVGAGAVNPEFLSDEDREVPAEALLDRVEREADLRRREEAADWVVCHGDLCLPNILVDPDRHTVEGFIDLGRLGLADRHADLALLLANTADTVPGFAEEATAGLAAGYPAQVDPERLRFYLALDPLTWG	148.82	gnl|BL_ORD_ID|1889|hsp_num:0	2052			477	651	streptomycin
BGC0000625.1|Thioviridamide_11 # 10392 # 11381 # 1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.699	BGC0000625.1|Thioviridamide_11 	10392	11381	+	Loose	750	28.1054	Yrc-1	27.03	3005035	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam	antibiotic inactivation	YRC Beta-lactamase	GTGGTGACGGACGCGGCACGCGACGCCTTCCGCGACCGGTTACGCCTCATCTACAACGAGGTCCGGATCGACGACGGGACCATCGTCCACTCCAGGCTCGGCCGGCTGCGTGAATCGCCCGACCTGGAGACGAAGGGCGCACCTCTGCTCAGCCACCTCTGGCGCCTGATCTACCTCTGCTACCACGCCGGCGATGAACGGGCGTCCAGGTTGCTGGTCGACGGAAGCAGGGCGACGACCTCGATCCAGGCCTGGGAGGAGCCGGCGGCGGTGACCAGGATGGAGGCGGCCCATGCCAGCAGGTGGACCCTGTCGCGGGGCTGGACGGTCGTCGACCGCGGCGCACTGATCCGCGCCGCCCGCTCAGGCGTCCAGCTGTCGTGCCGCCCCGACGAGGTCGAAGAGGCCGATGGTGACGGGCAGATCGCACTGCGCATGCCCGCGACCCAGCGCTACACGTTGTCCGGCTGGCTGGTGCTGCACGGCGAACTCGGCAGCGGTCGGCCCGACCACGTCTTCGTCAGGCACTATCTGTCGCTCCACGACGTGGGCAGCGCCGTCCGCGCCATCCACGCCCTGTCGGCCAAGCTGAACCAGGCGCGGGTGCGCTACCACATCAAGGTCGCCAACAACGCCGTCAGCCTGCGCAGGAGGGACGCCTTCATCATCTACTCGGAGGAGCACAGCGCACCTCTGGTGGAGCCGATCGTGTGCGATGCCGTGGAGAGCGGCCTGGTGGACGCGTCGTACACGATGCCGCTGTTCGCCGAGCAGGTCGCGCCCGGTTGGTCGACGGCCGTGGAGTCACGGCATCAGGACCCCAGCCTGTCCTACGGTCAGGCGTGCGCACGGGCCACGAGCCTCGGGGTGATCGAGGCGTGGGAGCGGGGCGCCCGGACGTTCGCAGACTGGTACGCGGCCGTGAGCGAACAGTTCGAAGCGTCGGGGATCGGCCCGCTGCGGTCGCACCGTCCCGGAGGCGCGCCGTGA	MVTDAARDAFRDRLRLIYNEVRIDDGTIVHSRLGRLRESPDLETKGAPLLSHLWRLIYLCYHAGDERASRLLVDGSRATTSIQAWEEPAAVTRMEAAHASRWTLSRGWTVVDRGALIRAARSGVQLSCRPDEVEEADGDGQIALRMPATQRYTLSGWLVLHGELGSGRPDHVFVRHYLSLHDVGSAVRAIHALSAKLNQARVRYHIKVANNAVSLRRRDAFIIYSEEHSAPLVEPIVCDAVESGLVDASYTMPLFAEQVAPGWSTAVESRHQDPSLSYGQACARATSLGVIEAWERGARTFADWYAAVSEQFEASGIGPLRSHRPGGAP	MMHKTLSCALLLVASGSTFATPQTEKKLSGIVDNVVIPLMKEQAIPGMAVAVIYQGQPYYFTWGMADVAGKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPVSKYWPALSGKQWEGISLLNLATYTAGGLPLQVPDNITDETSLQNYYETWQPQWAPGTKRFYSNASIGMFGKLAVKPSGMSFEQAMNKRVFQPLNLTHTWIHVPEREEKHYAWGYRDGKAVHVSPGMLDAEAYGVKSSIKDMASWVRANMTPSEVKDASLQKGILLAQSRYLQVGDMYQGLGWEMLNWPMKATIAVGGSDNKVALAPLSAVEINPPAPALNSSWVHKTGSTGGFGSYVAFIPEKNLGIVMLANKSYPNPARVEAAYRILEALSVE	85.90	gnl|BL_ORD_ID|2767|hsp_num:0	3779			84	414	cefoxitin; ceftazidime; cefuroxime; amoxicillin; cefalotin
BGC0000625.1|Thioviridamide_14 # 12883 # 14106 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.703	BGC0000625.1|Thioviridamide_14 	12883	14106	+	Loose	300	30.0314	Erm(37)	51.61	3000392	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGACTGAGAGCCTCAACCCCGACACGGTCATGTACCGGCGCCCCGACGTCCTGCTGGAGATCGACACGAGCAACAACTGCAAGGTGCATGTCGACGGCCGGACTCTCTCCTTCGGGCACGCCGCCGTCGGTCTGGTCGACGTCCTGCACCGGCCCCTGACCGTCTCCGAGGCGGTGCGGCGCGTGCGCTCGCGCACGGGAGGGCAACTGGACACCAGGGACGTGATGACCGATCTGGTCGGACTCGTCCACGCCGGGGTCCTGGACACCCGGCCGCGACTCGGGTTCAGCCCGCGGCCATGGCCGGCCGGCGGGTACGACTCCGCCTACGTGCACCTGCGGATACTCAACGACCGGCGTCGCAAGGGCGCTTTCGTCGCCGCGGTCCGCGAGACGGTCCGGCCGGGAGACGTCGTGCTCGACCTCGGGTCGGGGTCCGGCATCCTCGCCGTAGCCGCCGCTCAGGCCGGTGCCAGGAAGGTCTACGCCGTCGAACCTTCGGGAATGATCGGCCTGTCCGAAGCCGTCGCGGAGGCGAACGGCGTGGGCGATCGCATCGAGTTCATCCGAGACTGGTCGACGCGCATCGAACTTCCCGAGAAGGCGAGCGTCCTCACCACGGATCTGGTGGGCAACGAGCCGCTGGACATGAAGATCTGGGAGACGCTCACCGACGCGCGTCAGCGGCATCTGCGCGACGACGCCCGCATGGTTCCCGCTTCGTTCAGGAGCACAGCACGGTTCTACCGCGTCCCCGGCTCCTACCTGTCGGCCCACCGTGGCGCGCCGGCGGACGTGGCCACCTGGAACGACTGGTACGGGATCGACTTCTCACCGCTCGTCGACCAGGACGACCGGGCATGGATCGGAACGTACGAGCGGCCGGAAGTCATCCGTGACTGGCCGACCGCGTCGGACGAGGTCGCGGTGTACGAGTGCGACCTCGCATCCGACGTCAAGCCGTTCGAGGTCGTCACGGCGCCGGTGGACGTCGAGGCGGGCGCCAACGCCGTCGTTCTCTCCTACCGGGCCCGGCTCGGCCCGGGCACGGAGTTCGACGCCGATCCGCGCAAGGGCGGCGCCGACAGCCACTGGTACACGGCCGTGTGGCTGGCGGGCCGGGCAGCCGGACCCGTCGGACCCCGGGCGCGGGTCGAGTACAGGTACCGGGGCGACGGTTCGAGCGGGCTCCACGTCCGCCGCGTGGGGGGAGAGGCACAGTGA	MTESLNPDTVMYRRPDVLLEIDTSNNCKVHVDGRTLSFGHAAVGLVDVLHRPLTVSEAVRRVRSRTGGQLDTRDVMTDLVGLVHAGVLDTRPRLGFSPRPWPAGGYDSAYVHLRILNDRRRKGAFVAAVRETVRPGDVVLDLGSGSGILAVAAAQAGARKVYAVEPSGMIGLSEAVAEANGVGDRIEFIRDWSTRIELPEKASVLTTDLVGNEPLDMKIWETLTDARQRHLRDDARMVPASFRSTARFYRVPGSYLSAHRGAPADVATWNDWYGIDFSPLVDQDDRAWIGTYERPEVIRDWPTASDEVAVYECDLASDVKPFEVVTAPVDVEAGANAVVLSYRARLGPGTEFDADPRKGGADSHWYTAVWLAGRAAGPVGPRARVEYRYRGDGSSGLHVRRVGGEAQ	MSALGRSRRAWGWHRLHDEWAARVVSAAAVRPGELVFDIGAGEGALTAHLVRAGARVVAVELHPRRVGVLRERFPGITVVHADAASIRLPGRPFRVVANPPYGISSRLLRTLLAPNSGLVAADLVLQRALVCKFASRNARRFTLTVGLMLPRRAFLPPPHVDSAVLVVRRRKCGDWQGR	227.37	gnl|BL_ORD_ID|421|hsp_num:0	468			93	183	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000625.1|Thioviridamide_15 # 14103 # 15461 # 1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=4bp;gc_cont=0.675	BGC0000625.1|Thioviridamide_15 	14103	15461	+	Loose	250	28.8758	arr-7	34.15	3002852	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin ADP-ribosyltransferase (Arr)	GTGAAGCTGCGGAACTCGGTACCGAAGGTCGCCGGTGGCGGTCCTCACCGCGAAAGGACCACGGAGGAGACCTGGCGCACGATCCAGCCGTACCTGCGGCGCGTCGGTGTGACGCGGGTGGCCGACATCACCGGGCTCGACCGGATCGGGATCCCCGTCTACAACGCGATCGTTCCCAAGTCGAGTGACCTGATATCCGTGTACAACGGCAAGGGGGCGTCCCACCTGGACGCCAAGACGTCAGCCGTCATGGAGGCGGTGGAGCGATTCGCCGCGTGGCAGCCTCGGACACCGGATGTCGTCGGCTCGGTGGACGACCTCCGCCGCGACGGCATCCGCGTGGTGCATCCGGACTCGATCAACATCGAGCGCTTCAAGCAGTACCGCGACCACTTCCCGATCTCATGGGTCATGGGCACCGAACTGATCAGCGGTGAGGACATCGCCGTACCGCAGTACCTGGCCGGCTACTACCAGTCCTTCCACGAGACACCGCCCTTCCCGATCTGCACCACCAACGGGATCGCGTCGGGGAACTCGGTCGAGGAGGCCACCTGTCACGCGCTGTGCGAGTTGATCGAACGCGACGACTGGACCATGGCGGAGGTGATCAGCAACCGCCTCAGCCGCGCGGTGACCAAGGGCACGGTCGCGCCGGGCATCCCGGAGACCGTCGAGCAGTGGTTCATGGAACGCAACAGGTCCATCGACCAGGAGACGCTGCCGGCCCCGCACCGCCGGCTCATCGAGCGGTACCGGGCCGCGAACCTGTCGGTGGAACTCAAGAGCATCATGTCGCACAACGGGATCCCGAGCTTCCTGTGCGTCGTCTCGGAAGACCTGGGGCCCACCTTCTCCAGGAGCCACCAGGGCCTCGGCACGCACCCCGACCGTGACGTGGCCGCGCTCCGAGCGCTGAGCGAGGCGGCGCAGAGCCGGGTCGTGGACATCCAGGCGATGCGCGAGGACATCAGCCTGCCGGACGAGGACGTGCCCAAGTACATGCTGCACATCAAGCGCAGCGCGGCGTTCAATCCGCAAGCCTGGGCGAACTACCGGACCCAGCGGCAGACCGACTTCCAGTCACTGCCGACGTACCTGTCGGCGGACGTCATGGAGGACACCCGGCGGATGATCCGCAACCTCCAGGCGACCGGCATCGAGGAGGTGGCGGTCGTGGACCTGTCCCCCAAGTGGCTTCCGGTCTCGGTGGTCCGGGTCGTCGTGCCCGGCATCGAGTCGTGGGCGATCGACCGAGGCCGCCTCGGATTCCGTGCGGCCGCCGTGTGGGAGGAGAACCTGGGCCTCCTGCGGGACGCCCTCGCCGAGGCCGCGCACCGGCAGGAGGCACTGCGATGA	MKLRNSVPKVAGGGPHRERTTEETWRTIQPYLRRVGVTRVADITGLDRIGIPVYNAIVPKSSDLISVYNGKGASHLDAKTSAVMEAVERFAAWQPRTPDVVGSVDDLRRDGIRVVHPDSINIERFKQYRDHFPISWVMGTELISGEDIAVPQYLAGYYQSFHETPPFPICTTNGIASGNSVEEATCHALCELIERDDWTMAEVISNRLSRAVTKGTVAPGIPETVEQWFMERNRSIDQETLPAPHRRLIERYRAANLSVELKSIMSHNGIPSFLCVVSEDLGPTFSRSHQGLGTHPDRDVAALRALSEAAQSRVVDIQAMREDISLPDEDVPKYMLHIKRSAAFNPQAWANYRTQRQTDFQSLPTYLSADVMEDTRRMIRNLQATGIEEVAVVDLSPKWLPVSVVRVVVPGIESWAIDRGRLGFRAAAVWEENLGLLRDALAEAAHRQEALR	MPNDWIPTSHENCSLVPGPFYHGTKAKLAIGDLLSPGHPSHFEQGRRLKHIYFAALMEPAIWGAELAMSLSRQEGRGYIYIVEPLGPFEDDPNLTNKKFPGNPTKSYRTSESLRIVEVVEDWQGHSPDVLQGMLASLEDLQRRGLAIIED	301.33	gnl|BL_ORD_ID|679|hsp_num:0	736			321	444	rifampin; rifaximin; rifabutin; rifapentine
BGC0000625.1|Thioviridamide_17 # 16111 # 16953 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.718	BGC0000625.1|Thioviridamide_17 	16111	16953	+	Loose	800	25.0238	MuxA	24.74	3004073	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACGGCTGCGCGGAAGGGATTTCTGGAACGGGGATGGCGCCTGCCGGAACGGCGGCTGCCCGGCGGGACGGTCAGGGCGGTCCGGTACGCCGTCGTCAGCCACCTCGACGCGGCGGAACGGGCCGGCGGTGCGGCGCGGGCATGGGCGACGTTCCCCAAGCCGCACCTCGTCGTCCCCGCGATCGTGGAACTCGCCGACAGCCCCGAGATCACGGAATCGGTGGGTGACGTGCTCGGTGAAGCCTTCGGCATCTGGAGTTCCGCGATCTTCGTGTCGCCACCGGGCACCGGGACCGGCTTCGGCTGGCACCAGGACGCGCTCAGCTACGACCTCGACGGCGACGAGGGCCGGGCCCTGCGGGTCTGGGTCGCGCTGACGCCGGCCACCCCGGAGAACGGCACGATGTGGTTCGCCGACGGTTCGCACCGGTGCGGAACCCTCGACCACGACCTCGACGACCCGGTCCGAGGCCAGTCGGTGAGTCCGGACCGCGTACCCGGCGAGAAATTCCCGGTGGTGCTCGACGAGGGCGGGTTCAGCATGCACGACCTGCGTCTGGCGCACTCGTCGGGGCGGAACACGACGGACGGGCCAAGGATCAACGTGGCTCTGGACTACGTCGCTCCGGAGGCGGTGCCCGGAGCGGGCTGCGCCGGCGTACTGCCCCTGACCGCGGGCTTTCAGACCCCCTGGCGCGTGGAGCCCGACCCCCGGAAGGCAGCCGCGGCGCAGGCTCACGAGGCATGCGTCACCGAGTCCGCCCGGCGCCTTCGCAGTGCGATGGACCTTGCTGCCAGGGATGGTCTGCCCCTGGTGCTCGGGCCGGCTGATGACGCGTGA	MTAARKGFLERGWRLPERRLPGGTVRAVRYAVVSHLDAAERAGGAARAWATFPKPHLVVPAIVELADSPEITESVGDVLGEAFGIWSSAIFVSPPGTGTGFGWHQDALSYDLDGDEGRALRVWVALTPATPENGTMWFADGSHRCGTLDHDLDDPVRGQSVSPDRVPGEKFPVVLDEGGFSMHDLRLAHSSGRNTTDGPRINVALDYVAPEAVPGAGCAGVLPLTAGFQTPWRVEPDPRKAAAAQAHEACVTESARRLRSAMDLAARDGLPLVLGPADDA	MTPTTGKSKFRTLRPWLITALAFAAVIGLVMWLAAPASAPSSDGRPGRGGKPGAALPKANALTVGVARVEQGDLALHFNALGTVTAFNTVNVKPRVNGELVKVLFQEGQEVKAGDLLAVVDPRTYKAALAQAEGTLMQNQAQLKNAEIDLQRYKGLYAEDSIAKQTLDTQEAQVRQLQGTIRTNQGQVDDARLNLTFTEVRAPISGRLGLRQVDIGNLVTSGDTTPLVVITQVKPISVVFSLPQQQIGTVVEQMNGPGKLTVTALDRNQDKVLAEGTLTTLDNQIDTTTGTVKLKARFENADGKLFPNQFVNVRLLAQTLKGVLTIPANAVQRGTNGIYVYVVGADNKVSQRSVAIGTSENERVVVESGLKAGEQVVVEGTDRLRDGMEVRVAEASPQVLEGEPQKPQTGRPSGLQGDSVGSGSAE	65.73	gnl|BL_ORD_ID|2242|hsp_num:0	2717			204	468	erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
BGC0000625.1|Thioviridamide_19 # 17634 # 18482 # 1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.678	BGC0000625.1|Thioviridamide_19 	17634	18482	+	Loose	175	25.0238	vanT gene in vanG cluster	35.82	3002972	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	GTGACGTCTGGGAAGCGGGCTCGTGCCGCGCTTCGCTTCGTGACCCCGGCAGTCGTCCTGGCGAACGCGTTACTCGTGGTGACGGGAGTGTTCGACATCGGGCGTGCCGTACTCGTGGCGTTGGGGATGGAGGTGCTTCTCGCCGTCGTCACCGTGGTGTTGCTCGTGGCGGCGGGCACGACCTACCGCAGACGCCGGGAACTCGGCGACGGCCGCGGCCAAGCCCTCGCAGCCGCGGCGCAGGAGATTCTTCCGCCACCACTGTGGTCGCTGGCCCGGCACGAACTCGCCATTCTCAACGCACTGCTCCTGGTGCTTCGACGCAGGATCGACGCGCCCGACGGGGCTGCGACCTTCGGATACGGGAAGTCGCAGGCCCCGCTGTTCTACGGGCTGGCGGGCATCTCCCTGCTGGAGATCGTGTTGTTCGAGTGGCTGATCCCGTGGCCCTGGCTGAAGCTCACGATCGCGGTACTGTCGGTCTACGGCGCGGTCTGGGTGTTCGCCTTCTACCAGCTGATGCGGCGCAAACCGCACTACCTCACCGATCGGATGCTCGCGGTGCGGTGCGGGGCCATCGTCCGGCTCGACGTGCCGCTCGACGCGATCGACTCCGTCCGGAGCCAGATGGAGAACTGGGGCAACCGCTTCTACGAGGCCACCGACGACCAGGTCATCGCGATCAAGCCCGCCGGGTACACCAACGTGCGACTCCGGCTGAACCGTACGGTCGAGGCCGGGACCGGCCGGGGTCCGCTCAGCGGCACGTGTGTGTGCCTGGCCGCCGATGACCCGGACCTGCTGGTGTCGACCCTTCGCAAACAGCTGGTCGACCAGACAGCCGGCTGA	MTSGKRARAALRFVTPAVVLANALLVVTGVFDIGRAVLVALGMEVLLAVVTVVLLVAAGTTYRRRRELGDGRGQALAAAAQEILPPPLWSLARHELAILNALLLVLRRRIDAPDGAATFGYGKSQAPLFYGLAGISLLEIVLFEWLIPWPWLKLTIAVLSVYGAVWVFAFYQLMRRKPHYLTDRMLAVRCGAIVRLDVPLDAIDSVRSQMENWGNRFYEATDDQVIAIKPAGYTNVRLRLNRTVEAGTGRGPLSGTCVCLAADDPDLLVSTLRKQLVDQTAG	MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA	39.61	gnl|BL_ORD_ID|1522|hsp_num:0	1561			1788	1986	vancomycin
BGC0000625.1|Thioviridamide_20 # 18561 # 19043 # -1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.772	BGC0000625.1|Thioviridamide_20 	18561	19043	-	Loose	550	28.8758	KPC-60	34.44	3006189	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; penam	antibiotic inactivation	KPC beta-lactamase	ATGCCCGACGGCGCCGGCGTCCCGGCAGACGCCGCCCTCGGCATCGGCGCCCCGCTGAGCGGCCGCCCGCGCGAGGAGGTGCCGTTCCGGCCCGGACGCCTGCTGGCCGCCGTCACGATGCCCGCCCGTCCGGAGTCCGTTCCGGCGCTGCGCCGGCTGGCGCGGACGGTGGCGCGCAACCGCCGGCTGCCCGAGGAGGCCGAGGAGGCGCTCGGGGTGATCGTCACGGAGCTGGCCGCCAACGCCGTACTGCACAGCGGTGGTGCCGACGTCGCCCTGCTCCTGGAGATCGACGACACGGCGCTGACGGTGCGCGTGCGGGACAACGGTCAGTGGCGGGAGCGCCCCGCCCCCCGCTGCGAGCCCGCCGACCTGCACGCCGCGTTCGGCCGCGGCCTGACCCTCGTCGACGCGTACGCGGTCGACACCACACTCGAACGCACGGCCACCGGCACGGTGATGCGCGCGGTGGTCGCCCTGTGA	MPDGAGVPADAALGIGAPLSGRPREEVPFRPGRLLAAVTMPARPESVPALRRLARTVARNRRLPEEAEEALGVIVTELAANAVLHSGGADVALLLEIDDTALTVRVRDNGQWRERPAPRCEPADLHAAFGRGLTLVDAYAVDTTLERTATGTVMRAVVAL	MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYRAEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVTELSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTSSPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVYGTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ	54.61	gnl|BL_ORD_ID|3654|hsp_num:0	4723			153	417	
BGC0000625.1|Thioviridamide_21 # 19075 # 22254 # 1 # ID=1_21;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.779	BGC0000625.1|Thioviridamide_21 	19075	22254	+	Loose	150	29.261	nimH	25.89	3007110	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic inactivation	nitroimidazole reductase	GTGGTCTCGTCCATTGTCAGGACTCCTGTCCTGCGCTGCCGGCTGGGGGCGGTGACGGCCCCCGCCGGCCTGAGTGGCCGAGAGGCCTTGACCCGTCCCACGCTCCCCGTGCCGCCCGCGGGGCGGCAAGCAGGAGAGACTGATTACGGATACTCAAAGAATCGGGACATGCCGGATACCAGGGTGACGGTGACGCACGTGGCCGAACTGACCGAGAACGCGCTGCGCGGGCTGCTGGCTCGCGGGCTGGCCGACGGGGACGGTACGGGGCCTGTCCTGCTGCTCATCGAGGGCGCCGCCGGCACTGGCAAGACCAGGCTGCTGAACCGGCTGCTGTCCGGCCTGCCGGTGCCGGCCCGCACGAGCGCCGCCGCCGTTCTCGCCGCAGCTGATCCAGGGGGCCGGGGGCCCGGTTCAGATCCCGACTCGGGATCCGGCCCCGGTCTCGGGCCGGATGCTGGTTCTGGTCTCGGTCCCGGCTTCGGTTCAGGCCACGGTCTCGGTCTCGGTTCGGGACCCGCTCCCGGCCCAGGTCTCGGTTCAGGCCCCGCCCCAACTCCCGGCCCCGCTCCCGGTCCGAGCACCACCGGCGCCGGCTCCCGCCCCGCCCCCCTCCTCCTCGCCGTGGAGGACGTCCACCGGGCCGGTGCGGACGAAATGGCCGCTCTTCGGGTGCTGCTCGCGGCGCCGCCCGCGCGGTTCGCCTGCGTTCTCACCCACCGCCCGGAGGAACTCGCCGAGCCGGGGCTGGTCCTCGGCGCGCGGACCGAGTTCCCGGCCGGGCTCACCGTCGTACGGCAGACCCTCGGCCCCCTCGACCGGGCCGCCGTCGGCCGGTTCGCCGCCGCCGTGCCGGGGGCGGGACACTGCACGGCCGATCTGGTCACCGCGCTGCACCACGCCTCCGGGGGCAACGCCCAGACCGTCTCCGACCTGCTGGACCTGCTCGCCGCGCACACCGCCGGGCGTCGCGAGGCGCAGCCCGGCCCGGGCGACCTGGAGCGGATCGGCGTACCGCCCCGGCTCGCGGCGCTCGCCCTGCGCCGGACCGCCGCCGTACCCGAGGCGCACCGGCCCGTCGTGTTCGCCGCCGCCGTTCTGGACCGGCCCGCGACCGCGCGCGAGCTGGCTGCCGTCGCCGGGCTGTCCGAGTCCCTCGGCAGGGCCGCGCTGCTCGCCGCGTTGCGTGGCGCCGCGCTGTGCGAGCACGGCGTCGGCAGGTACGGCTTCGCCGCGCCGCTCGCCGCCGCCGCCGTACGCCGGGAACTGCCCGGCCCGGTGCGGGAGGCCCTGCACGGGCGGGCCGCCGCGCTGCTGGCCCGGCAGCAGCCGGTGCCGTGGGAGCGGCTGGCCGCGCACCGGCGGGCCTGCGGTGACCAGCGCGGCTGGCTGCGCGCCGTGGAACGGGCCGCGCAGGAGTTCGCCGACACGGGCGAGATCCAGCGCGCGGTACGGCTCCTGGAGGACGCCCTGTCCGGCGGCGAGGTCCCCGCGCACGCCCGCTCCCGGCTCGCCACCCTGCTCGCCCGCAGCGCCGTCATGGGCCTGCGCTCCGACCAGACGCTGGAGGTGCTGCAGAACATCGTCGCCGGCGCCGACCTCCCGCCGACCGTGCGCGGCGAGATCCGGCTCGACCTCGGGCTGCTGCTGTGCAACCAGATGGGCCGCATCCTGGAGGGCCAGGCCGAGCTGGTCCGGGCCGTCGACGACCTGGCCGGGCAGCCGGTGCCGCTGGCCCGGGCGATGTCCGCGCTGTCCATGCCCTACTGGCCGGGCATGCCGCTCGCCGACAACATCGCCTGGCTGGAGCGCGCGGTGACCGTGGCCGCCGAGTCCGGGGACCCCGTCGTCCAGGCCGCCGTCGCCGCGAACCAGGTCAGCGTGCTGCTCAACATCGGCGACCCGGCGGCCTGGCCGCTGATCGACGCCCTGCCCCGGCACAGCGAGCTGCTCGGCGCCCGCCAGCAGGCCTCCCGCGGGCTGTGCAACGCCGCCGACGCCGCCGCCTGGCTCGGCCACTACCGGCAGTGCCGGGCCCTGCTGGACGAGGGCGTCGCGCTCGCCGCCCGCAACGGCGCCGCGTACGCCGAGCAGACCGGCCGGGGCGCCATCCTCGTCCTTGACTGGGCCACCGGCCGCTGGGCCGGGCTCGCCGCGCGGGCCCGCGCCCTGGTCGACGAGGTCGGTGACATGGCCTCCGGCGCCGACGCCCGGATGGTCCTCGGCCTCCTCGCCCTCGCCCGGGGCGAGTGGGCCGACACCACCGAACACCTGACCGGCCCCGATTCGCTCGACCGGGACAGCGGCCCCGTCCCGCTCTCCGCGACCGCCTCGGGCGCCCTGATCCGGCTCGCCCTCGCCCGCGACGAGACCGGCCCCGCCGCCGCCGAGGCCGACGCCGCCTGGCAGCGGCTGCGCGCCAAGGGCGGCACCTGGGCCTGGGGCGCCGACCTCGCGCCCTGGGCGGTCGAGGCGACGGTGCGGGCCGGGAACGTCTCCGGGGCCCGCGAGATGACCGCCGAGTTCGCCGCCGGGCTGGAGGACCGGGACGCGCCGTCCGCCGACGCCGCGCTGGAGTGGACCCGGGGCGTCCTCGCCGAGCACACCGGCGACCCGGCCGTGGCCGTCCGGCACTACGCGGCCGCCGCCGAGGCGTACGCCGCCATGCCCCGCCTCTACCACGCGGCCCTCACCGCGGCCGCCGCCGCCCGCTGCGCGCTCGCGCTGGGCATCGACCCCGGCCTCGACGGTCCGCTCCACACGCTCCACCCGCTCCACCCCGGCCCGGATGGCGGGCCGGGCTTCGGGCCGGGCCGCCGTGCGGACACCGGGCCCGCCGTCGCGGCGCTCGCCGACTGCGCCGACCGGTTCGAGGCGCTCGGCGCCACCTGGGACGCCGCCCGGACCCGTGCCGACCTGCGCGCACACAGCCCGGCCGAGGAACGGCGGGCGCCCGGCCGGCCCAGCTACGGCGATCTGCTCTCCCCACGCGAGGCGGAGGTCGCCGAACTCGCCGGCGCCGGCATGACCAACCGGGAGATCGCGGCCGCCCTGCACCTCTCGCCGCGCACCGTCGAACAGCACGTGGCCCGGGCCCTGCGGAAGACCGGCGCGCACTCCAGGCAGCAGCTCTCCTCGGCGCACCGCGCGGCGGCTCCCGCCGAACCGACTGCCGAGTGA	MVSSIVRTPVLRCRLGAVTAPAGLSGREALTRPTLPVPPAGRQAGETDYGYSKNRDMPDTRVTVTHVAELTENALRGLLARGLADGDGTGPVLLLIEGAAGTGKTRLLNRLLSGLPVPARTSAAAVLAAADPGGRGPGSDPDSGSGPGLGPDAGSGLGPGFGSGHGLGLGSGPAPGPGLGSGPAPTPGPAPGPSTTGAGSRPAPLLLAVEDVHRAGADEMAALRVLLAAPPARFACVLTHRPEELAEPGLVLGARTEFPAGLTVVRQTLGPLDRAAVGRFAAAVPGAGHCTADLVTALHHASGGNAQTVSDLLDLLAAHTAGRREAQPGPGDLERIGVPPRLAALALRRTAAVPEAHRPVVFAAAVLDRPATARELAAVAGLSESLGRAALLAALRGAALCEHGVGRYGFAAPLAAAAVRRELPGPVREALHGRAAALLARQQPVPWERLAAHRRACGDQRGWLRAVERAAQEFADTGEIQRAVRLLEDALSGGEVPAHARSRLATLLARSAVMGLRSDQTLEVLQNIVAGADLPPTVRGEIRLDLGLLLCNQMGRILEGQAELVRAVDDLAGQPVPLARAMSALSMPYWPGMPLADNIAWLERAVTVAAESGDPVVQAAVAANQVSVLLNIGDPAAWPLIDALPRHSELLGARQQASRGLCNAADAAAWLGHYRQCRALLDEGVALAARNGAAYAEQTGRGAILVLDWATGRWAGLAARARALVDEVGDMASGADARMVLGLLALARGEWADTTEHLTGPDSLDRDSGPVPLSATASGALIRLALARDETGPAAAEADAAWQRLRAKGGTWAWGADLAPWAVEATVRAGNVSGAREMTAEFAAGLEDRDAPSADAALEWTRGVLAEHTGDPAVAVRHYAAAAEAYAAMPRLYHAALTAAAAARCALALGIDPGLDGPLHTLHPLHPGPDGGPGFGPGRRADTGPAVAALADCADRFEALGATWDAARTRADLRAHSPAEERRAPGRPSYGDLLSPREAEVAELAGAGMTNREIAAALHLSPRTVEQHVARALRKTGAHSRQQLSSAHRAAAPAEPTAE	FREMRRKRQLLPTEESITILEKMTNGTLALHGDNGYPYAVPVSYVYADGKIYFHSAVKGHKVDAILRNNKVSFCVVEQDDVKPAEFTTYFRSVIAFGKARILADEGEKQLAFRLLADKYSHGEVGMEAEIAKGFNHLLMVEIMVEHMTGKE	701.32	gnl|BL_ORD_ID|4787|hsp_num:0	5783			54	384	metronidazole
BGC0000625.1|Thioviridamide_22 # 22617 # 22901 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.751	BGC0000625.1|Thioviridamide_22 	22617	22901	+	Loose	750	23.0978	smeA	46.15	3003051	protein homolog model	n/a	n/a	aminoglycoside antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTGCCGGTGTTGAAACTGCTGGAACACGAGGAGCGCGTCGCCCGCGAGCGGGTGGAGTCGCTGCGCGCGGAGGCCGACCGGGTCCTGGACGAACTGGCGCGCGCGGAGACGGACTGGGAGGGCTGGGCCGTCGCCCGGCAGCGGGTCAGGCAGGTCATGTCAGCGCCGGCCGAGGGGAAGACCGGCACCGGCGCCGCGGAGGCCGCGCTCACGGCCGCACGGCAGGAGACCGTCTCCGCGCACGAGCGCGTGCTGGACGCCAGAGCGTGGGCCGCCGACTGA	MLPVLKLLEHEERVARERVESLRAEADRVLDELARAETDWEGWAVARQRVRQVMSAPAEGKTGTGAAEAALTAARQETVSAHERVLDARAWAAD	MSLLRPLSRSPRPLLLPLLLALAACSADRTDAPAMPEVGVIIASAQPLALQQTLPGRAVPFEISEVRPQIGGLIRQRLFTEGQQVKAGQLLYQVDPAPYQAAFDTARGQLAQAEATVLSAQPKAERTRALVSMDAASKQDADDATSALKQAQANVIAARAALQAARINLDYTRVTAPIDGRIGTSSVTAGALVAAGQDTALTTIQRLDPVYLDVTQSSTQMLALRKRLDAGLVKAIDGKAQVKVLLEDGSTYAHEGTLEFVGSAVDPGTGNVKLRAVIPNPDGLLLPGMYLKAVLPMATDARALLVPQKAVVRNERGEPLLRLLDAKDHVVERRVSTGQVVGNQWQITSGLKAGERVIVSNGSAVSLGQQVKAVAPTTAQLAAMPAVDPNGNTDEKSH	23.62	gnl|BL_ORD_ID|1388|hsp_num:0	1507			519	597	
BGC0000625.1|Thioviridamide_23 # 23354 # 26623 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.761	BGC0000625.1|Thioviridamide_23 	23354	26623	+	Loose	1050	34.2686	YojI	28.36	3003952	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGCGGCGGTGCGAGCTGCGGTTCGGGCTGCTGGGACCACCGGTCCTCTACGACCGGTACGACCCGGACGACACCGTCTCCGAGCAGCCGGTCCGCGTGATCGGCAGCCCCAAGGTCCGTGCGCTGCTGGCCGCGCTGCTCCTGGAGGCCGGCCGGGTGGTGTCGGTCGAGTCGCTCAAGGACGCCCTGTGGGGCGGCGCGCCGCCCGCCTCCGCGCAGGCGTCCCTGCACAACCACGTCACCCGGCTGCGCCGGCTCCTCGACGACCCCGAGCGGCTCAGGGCCGTCGCGCCGGGCTACCTGCTGCGCGTCAACGGCGGCGAGTTGGACGTGCACGTGTTCGACGCCCGCGTCGCCCAGGCACGCGCCGCGCACGCGCGGGGCGACTGGGAGCGGGTCGTGGAGACCTGCACCGCGGCGCTGACGCTGTGGCGCGGCACGCCCCTCAGCGGCGTCCCCGTCGGCGTCGGCGGCTACGCGCTGGTGCAGCGCCTGGAGGAGGCGCGGCTGCTCGCCCTGGAGTGGCGCTACGACGCCGAACTCGCCCTCGACGGCGACCGCTTGACCGCCCTGGCTCCGGAACTGGCGGCCCTGGTCGCCGAGCACCCGCTGCGCGAGGCGTACCACCGCCAGCTGATGCTCGCCCTCCACCGCACCGGCCGCCAGGCCGAGGCGCTCGCCGTCCACCGCGACCTGCGGGCCCGCCTCATCGACGAACTCGGCATCGAACCGGGCCCCCAGGTCCGCGACACCCACCTGCAGATCCTCCGCGACTCCCCGCCCCCGACGCCGGCGGCGGAGCCCCAGACAGCCTCAGGCACCCAACCGGCCGTCCCAACCGAAACAGCCCGAACCGAAGCAGCCCGAACCGAAGCAGCTCAGGCACCGCTGCCCCCACCCCCGGAACTCTCGCCGTCCACCGCATCCCGGCCCGCGCCGCCGGAAGGGACGCCGCACGCCACAGCACCACCCGAGGCCGCCGACGGTGCAGACCCCCCACAGGGGCCACCGGCACCCGACGACGAAACCCGCACGGGTGGTGCGGGTGGGAACCCCTATGCGGCCGAAGGCCGCCAAAGCCCGCACCCTCACCCACCCGCACCCGCACCCGCACCCGCCCAACTCCCCCCACCCCCAGCCCACTTCACCGGCCGGACCACCGAACTCACCGACCTCCACCACACCCTCACCGCCGAGCGCGGCGAACTCGCGGTGATCAGCGGGATGGCCGGCGTAGGCAAGAGCGCCCTCGCCCTGCACGCCGCCCACGCCCTGCGCGGACGGTTCCCCGACGGCCAGCTCTACGTCAATCTGCGGGGCGCGGCCCCGGGCATGACCCCCCTCGACGCCCCGCAGGCCCTCGCCGCCCTGCTCAGGGACCTCGGCGTGGACCCGCGCGGCATCCCCGAACACCCGGACGCGGCAACGGCGTTGCTCCGCTCCCTCCTCGCCCCCACCCGCACCCTCATGGTGCTGGACGACGCGGCCAACGCCGCCCAGGTACGGCCCCTGCTGCCGGCCGGCCCCGGCTGCGCCGTGATCGTCACCAGCCGCTCGCCGCTGACCGCCCTCGACGGCGCCCGGCGCTTCCCGCTCGGACCGCTGCCGGAGGAGGACAGCGCGGCTCTGCTACGCGCGGTGAGTGGACGCGACGGCCTCGACGCCTCGCACGCCCTCGTGGGGCTGACCGGCGGGCTGCCGCTCGCCCTGCGGGTCGTCGCCGCCCGCCTCGCGGCCCGCCGCGCGCTCACCCCGGACGTGCTCGCCGGCCAGCTCACCGCCACCGGCGGGCGCCTGCGGCACCTGGAGTACGACGACCTGAGCGTCCGCCGGTCCCTCGCCGTCGCACACGACGCGCTCGCCGCGAGCGAGCGGGAGACCGATCGGGACGCGGCCCGCGCCCTGCCCCGTATCGGCGCGCTCGACCTGCCGACGTACGGCGCCCCGCTGATCGCCCGCCTCACCGGCACCGACGAGCCCCGCGCCGAGGCCGCGCTGGACCGCCTCGTCGACGTGGCCCTGCTGGAGGAGACGGCGTACGGCCGCTACGTCCCCCACGGCCTGGTCCGCGACTTCGCACGCGAACTGGCCGGCGGCGACGGCCGCGCCCCGGACGGCACCCGTACCCCCGCCTGCCCCGACGCGGCCGCCCTCCGCTGGTACGCCGCCGTCACCGAACGCGTCCTCACCGCCGCCGTCGGACCCGGCCTCGACCGGGACGACCGGCTCCGCTCCACCGCCGCCCAGCCCGCGCGGCACGCGGCGGACGTGTCGGCCGTACCGTCCTTCGCGTCGGACCAGGAGGCCTTCGCCTGGGCCGACGGCGAACTGGAGAACATCGTCACCCTGGTCGCGCGGCACGCCGCCACCGCCGACGGGACCACCGCCGCTCACCTCTGCACCGTGGTCCGCCTCCTGTTCCCGTACGTACGGGGCAGCGGGCGGCTCGCGGAGATGGAGGTGCTCGGGCGGGCCGCGCTCAAGGCGGCGCGCCGGCTCGGGGACGCGGCGGCCGAGGCGTGCGCGCTCGTCGACCTCGCGGGCCTGCACTTCCTGACCGGCCGGCACAGCGAGGCCCTCGCCCTCAACGACGAGGCCCTGGACATCTGGCGGCGGCTCGGCACCGTCTCCTGGATCCGCCGCTGCCTGAACAACCGCGGACTGCTCCTGGACGGGCTCGGACGGCTCGCCGAGTCCGAGGACGCCCTGCGGCAGAGCCTGACCTACTCCCGGCAGCTGAACGACCCCTACGGCGAGGCGATCACCCACAGCCATCTCGGCAACCTCTTCGAGCACACCGACCCGCGCGCCGCCATCGAGCAGCACCGGCGGTCGCTGTCCATCGGGGAGACCATCGGCGCGGTCATCGTGCGGCACACGGCGCACTGCAACATCGGCTACGCCCACCTCACTCTCGGCGAACCGGCCGCCGCCGCCCGGCACTTCGAGCAGAGCCTGCGGATCCTCGGCGACCACGGTGACTGGCACGGCGAGTCGCAGACCCGGCTGGGCCTGGTGCGGGCGCTGCGGCTGCTGGGCGACCCCGTGCGTGCGGGCTGGGAGTGCGCCGAGCTGCTGCGCCGCGCGGACGACCGCGCCGACCGCTACGTCGGCGGTCTCGCCCGCCACCAGTCGGGTCTGCTGCTGCGCGACGAGGGACGCCACACGCAGGCGTACGACACCTGGCGCGCGGCCCTCGCGGCGCTCGACGGCACCGACGAGCAGACGGTGGCCGCCGAACTGCGGGAGCTGCTGGCCGAGGGGCCGTAG	MRRCELRFGLLGPPVLYDRYDPDDTVSEQPVRVIGSPKVRALLAALLLEAGRVVSVESLKDALWGGAPPASAQASLHNHVTRLRRLLDDPERLRAVAPGYLLRVNGGELDVHVFDARVAQARAAHARGDWERVVETCTAALTLWRGTPLSGVPVGVGGYALVQRLEEARLLALEWRYDAELALDGDRLTALAPELAALVAEHPLREAYHRQLMLALHRTGRQAEALAVHRDLRARLIDELGIEPGPQVRDTHLQILRDSPPPTPAAEPQTASGTQPAVPTETARTEAARTEAAQAPLPPPPELSPSTASRPAPPEGTPHATAPPEAADGADPPQGPPAPDDETRTGGAGGNPYAAEGRQSPHPHPPAPAPAPAQLPPPPAHFTGRTTELTDLHHTLTAERGELAVISGMAGVGKSALALHAAHALRGRFPDGQLYVNLRGAAPGMTPLDAPQALAALLRDLGVDPRGIPEHPDAATALLRSLLAPTRTLMVLDDAANAAQVRPLLPAGPGCAVIVTSRSPLTALDGARRFPLGPLPEEDSAALLRAVSGRDGLDASHALVGLTGGLPLALRVVAARLAARRALTPDVLAGQLTATGGRLRHLEYDDLSVRRSLAVAHDALAASERETDRDAARALPRIGALDLPTYGAPLIARLTGTDEPRAEAALDRLVDVALLEETAYGRYVPHGLVRDFARELAGGDGRAPDGTRTPACPDAAALRWYAAVTERVLTAAVGPGLDRDDRLRSTAAQPARHAADVSAVPSFASDQEAFAWADGELENIVTLVARHAATADGTTAAHLCTVVRLLFPYVRGSGRLAEMEVLGRAALKAARRLGDAAAEACALVDLAGLHFLTGRHSEALALNDEALDIWRRLGTVSWIRRCLNNRGLLLDGLGRLAESEDALRQSLTYSRQLNDPYGEAITHSHLGNLFEHTDPRAAIEQHRRSLSIGETIGAVIVRHTAHCNIGYAHLTLGEPAAAARHFEQSLRILGDHGDWHGESQTRLGLVRALRLLGDPVRAGWECAELLRRADDRADRYVGGLARHQSGLLLRDEGRHTQAYDTWRAALAALDGTDEQTVAAELRELLAEGP	MELLVLVWRQYRWPFISVMALSLASAALGIGLIAFINQRLIETADTSLLVLPEFLGLLLLLMAVTLGSQLALTTLGHHFVYRLRSEFIKRILDTHVERIEQLGSASLLAGLTSDVRNITIAFVRLPELVQGIILTIGSAAYLWMLSGKMLLVTAIWMAITIWGGFVLVARVYKHMATLRETEDKLYTDFQTVLEGRKELTLNRERAEYVFNNLYIPDAQEYRHHIIRADTFHLSAVNWSNIMMLGAIGLVFWMANSLGWADTNVAATYSLTLLFLRTPLLSAVGALPTLLTAQVAFNKLNKFALAPFKAEFPRPQAFPNWQTLELRNVTFAYQDNAFSVGPINLTIKRGELLFLIGGNGSGKSTLAMLLTGLYQPQSGEILLDGKPVSGEQPEDYRKLFSAVFTDVWLFDQLLGPEGKPANPQLVEKWLAQLKMAHKLELSNGRIVNLKLSKGQKKRVALLLALAEERDIILLDEWAADQDPHFRREFYQVLLPLMQEMGKTIFAISHDDHYFIHADRLLEMRNGQLSELTGEERDAASRDAVARTA	199.09	gnl|BL_ORD_ID|4707|hsp_num:0	2424			906	1296	microcin J25
BGC0000625.1|Thioviridamide_24 # 26660 # 28345 # -1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.759	BGC0000625.1|Thioviridamide_24 	26660	28345	-	Loose	920	26.5646	OpmD	41.38	3000809	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCCGACCGCTGGGCACTCGCACCGGCCGAGGACGGAGGCGTGGACGTCGCCCCCCTCGGCCCGGACGGGCTGCCCGCCGGTCCGGTGCGGCGGGAGTCCGATCTCGCCGGGGCGGTGCGGAGCCGCCCGGAGGTGACGCGCTGGGTGTGGCGGTCCACCCCCGAGGTCTACCCGCGTCTGCTCGCCACGGGGGTGCGAGTGGAGCGGTGCTACGACATCGAGGACGTCGAGACACTCCTGCTGGGCCACGAGGGACGGTCCGGCGAGCCGCGCTCGGCCGCCGCCGCCCTGGCCCGCCTCCGCGGCGGCCCCGTACCTCCCGATCCGCGGCAGCGCGCGGCCGATCCGGGCGCCCAGTCCCCGCTGTTCGAGCCGCAGGGCGCCCCCCTGCCGCTCGACGACCTCCTCGCGGTCTACGCCGACCAGCAGCGGCGGCACGAGAAGGCCACCCACCCCGACCGGATGCGGCTGCTGACCGCCGCCGAGTCGGCGGGCATGCTCATCGCCGCCGAGATGAACCGGGCCGGCCTCCCCTGGAGCGCCGACGTCCACCGCGCCCTGCTGCACGACCTGCTCGGCGAGCGGTACGCGGGCGGCGGCGAACCCCGGCGCCTCGCCGACCTGGCGGACCAGGTGTCGGCCGCGTTCGGGCGCCGCGTCCGGCCCGACCTGCCCGCCGATGTGATCAAGGCGTTCGCACAGGCCGGCATCAAGGTGAGGTCGACGCGCCGCTGGGAGATCAGCGGAGTCGACCATCCGGCGGTCGAACCCCTGCTGGAGTACAAGAAGCTGTACCGGATCTGGGTGGCGCACGGCTGGTCCTGGCTGCACGACTGGGTGCGCGACGGCCGGTTCCGTCCGGAGTTCGTCGCCGGCGGCACGGTCACCGGGCGGTGGGTCACCAACGGCGGGGGCGCGCTGCAGATCCCCAAGGTGATCCGCCGGGCCGTGGTCGCCGACCCGGGCTGGCGGCTGGTCGTGGCCGACGCCGACCAGATGGAGCCCCGCGTGCTCGCCGCGATCTCCCGGGACCCCGGCCTCATGGAGGTGGCCGGCCGGGCGAGCGACCTGTACCAGTCCGTCTCCGACCGCGCGTTCTCCGGCGACCGGGACCAAGCCAAGATCGCCGTGCTCGGCGCGGTCTACGGCCAGACCTCCGGCGACGGCCTGAAGAACCTGGCCGCGCTCCGCCGCCGCTTCCCCCGCGCGGTGGCGTACGTCGACGAGGCCGCGCGGGCCGGCGAGGAGGGCCGGCTCGTGCGCACCTGGCTCGGCCGCACGTGCCCGCCGGTCGCCGGGGCGGACGAGGGCGCGGCGGAGGAGGCGGGCATCCCCGTCGGCGAGGACGACACCGACGGCCGCTCCTGGGCACCCGGCCACTCCTCCACCGACTCCCGCGCGCGGGGCCGCTTCGCGCGGAACTTCGTCGTCCAGGGCAGCGCCGCCGACTGGGCCCTGCTGATGCTCGCCGCGCTGCGCCGGTCCTGCGCGGGCCTTGCCGCCGAACTGGTCTTCTTCCAGCACGACGAGGTGATCGTGCACTGCCCCGCCGAGGAGGCCGACACCGTCGTCCGGGCCATCGGCGACGCCGCCGGTCTCGCCGGCCGGCTGACGTTCGGGGAGACACCGGTCCGGTTCCCGTTCACGACAGCGGTGGTGGAGTGCTATGCGGACGCCAAGTGA	MADRWALAPAEDGGVDVAPLGPDGLPAGPVRRESDLAGAVRSRPEVTRWVWRSTPEVYPRLLATGVRVERCYDIEDVETLLLGHEGRSGEPRSAAAALARLRGGPVPPDPRQRAADPGAQSPLFEPQGAPLPLDDLLAVYADQQRRHEKATHPDRMRLLTAAESAGMLIAAEMNRAGLPWSADVHRALLHDLLGERYAGGGEPRRLADLADQVSAAFGRRVRPDLPADVIKAFAQAGIKVRSTRRWEISGVDHPAVEPLLEYKKLYRIWVAHGWSWLHDWVRDGRFRPEFVAGGTVTGRWVTNGGGALQIPKVIRRAVVADPGWRLVVADADQMEPRVLAAISRDPGLMEVAGRASDLYQSVSDRAFSGDRDQAKIAVLGAVYGQTSGDGLKNLAALRRRFPRAVAYVDEAARAGEEGRLVRTWLGRTCPPVAGADEGAAEEAGIPVGEDDTDGRSWAPGHSSTDSRARGRFARNFVVQGSAADWALLMLAALRRSCAGLAAELVFFQHDEVIVHCPAEEADTVVRAIGDAAGLAGRLTFGETPVRFPFTTAVVECYADAK	MKRSYPNLSRLALALAVGTGLAACSVGPDYQRPQSPPPRVASEHLGEFSGERREAPWWSFFDDPQLVRLVDQALARNHDIREARANLRSARALFDDRWLDQLPQVTSQAGYSRSIEQQLDYDGEPRRRLAESYRAGFDAQWEIDLFGRLGRLSDAALARAEAADADLRLVRLSIAADTARAYFEIQGYQRRLDVARAQVRSWRDTLELTRSSLQLGSGLPEDVENAQANLLRSEAAIPPLTTALESARYRLDVLRGEAPGSGAPILDGGAAAPLAKNLPLGDVDRLILQRPDVVSAERQLAASTEDVGAATAELYPRLDLGGFIGFFALRSGDLGSASRAFELAPSVSWPAFRLGNVRARLRAVEAQSDAALARYQRSLLLAQEDVGNALNQLAEHQRRLVALFQSATHGANALEIANERYRAGAGSYLAVLENQRALYQIREELAQAETASFVNVIALYKALGWGSGDLAPGAGQLAAGETAGANR	115.20	gnl|BL_ORD_ID|450|hsp_num:0	442			786	954	acriflavine; tetracycline; norfloxacin
BGC0000625.1|Thioviridamide_25 # 28553 # 29323 # -1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.693	BGC0000625.1|Thioviridamide_25 	28553	29323	-	Loose	900	25.409	ANT(3'')-II-AAC(6')-IId bifunctional protein	31.18	3002598	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	aminoglycoside bifunctional resistance protein	ATGGCGACCAATCCGAACATCACGGCATCCGTACGCCTCGACGACCTCATCGAGGCGATCAAGAAGGTTCACCCCGAACCCCTCGACCAGCTCCAGGACGCGGTGATCGCCGCCGATCACCTCGGTGACGTGGCCGACCACCTGATCGGGCACTTCGTGGACCAGGCCCGCCGCTCGGGCGCCTCCTGGACCGAGATCGGCAAGAGCATGGGCGTCACCCGGCAGGCGGCGCAGAAGCGGTTCGTGGCCAAGGAGTCGGCGGACCTCGACCCCAGCCAGGGCTTCAACCGCTACACCCCGCGCGCGCGGAACGTGGTCATGGCCGCGCACAACGAGGCGGTGGCCGCCCGCAACGCCGAGGGCCGCCCCGAGCACCTCGTCCTCGGCCTGCTGGCCGAACCGGAGGGCCTCGCCGCGAAGGCGATCGTCTCGCAGGGCGTTTTGCTGGACGCCGTACGCCAGGCGGCGACCGCCGCGCTTCCCCCGGCCGCGGACGACGTACCGGAACTCGTCCCGTACGGCCCCGACGCCAAGAAGGCCCTCGAACTCACCTTCCGCGAGGCCCTCCGCCTCGGCCACAACTACATCGGCACCGAGCACATCCTCCTGGCCCTCCTGGAACACGAGAACGGCCACGGCGTCCTCAATGACCTCGGGATCACCAAGCCCGCCACCGAGCAGTACGTCAACAGGGTCCTCGCCCTCCTCCTGGAACAGAAAAAGGCAGCGGGCGCGGCAGCGGAAGCGGCAACAGACACCCCGGAGTCCTGA	MATNPNITASVRLDDLIEAIKKVHPEPLDQLQDAVIAADHLGDVADHLIGHFVDQARRSGASWTEIGKSMGVTRQAAQKRFVAKESADLDPSQGFNRYTPRARNVVMAAHNEAVAARNAEGRPEHLVLGLLAEPEGLAAKAIVSQGVLLDAVRQAATAALPPAADDVPELVPYGPDAKKALELTFREALRLGHNYIGTEHILLALLEHENGHGVLNDLGITKPATEQYVNRVLALLLEQKKAAGAAAEAATDTPES	MSNAVPAEISVQLSLALNAIERHLESTLLAVHLYGSALDGGLKPYSDIDLLVTVAAQLDETVRQALVVDLLEISASPGQSEALRALEVTIVVHGDVVPWRYPARRELQFGEWQRKDILAGIFEPATTDVDLAILLTKVRQHSLALAGSAAEDFFNPVPEGDLFKALSDTLKLWNSQPDWEGDERNVVLTLSRIWYSAATGKIAPKDIVANWAIERLPDQHKPVLLEARQAYLGRGEDCLASRADQLAAFVHFVKHEATKLLGAMPVMSKTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA	55.29	gnl|BL_ORD_ID|4929|hsp_num:0	339			249	513	dibekacin; sisomicin; netilmicin; spectinomycin; streptomycin; tobramycin; gentamicin A; 2'-N-ethylnetilmicin; 5-episisomicin; gentamicin
BGC0000625.1|Thioviridamide_26 # 29455 # 30576 # 1 # ID=1_26;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.760	BGC0000625.1|Thioviridamide_26 	29455	30576	+	Loose	960	26.5646	lsaC	24.05	3003112	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; pleuromutilin antibiotic	antibiotic target protection	lsa-type ABC-F protein	GTGACCAGTGAAGCCAGTACCGTCGAGCGGGCGTTTCGGGGCGCCCTCTACGACGACACCGACGCCGGACTCGACACGGGCGCCTCCCTGCTCGCCGCCGACCCCGGTGCCGACGCCGAACTCGCCCGGCGCGGCGAGGAGTTCATCGCGGCGGCCTGGCAGCGCGGCTGGCAGCCCGCCGACGTCGTCCGGCTGGTCCGGCGCGAACTGGACGAGACGCACGTGGTCCTGGCGGCCCGCCTCATCCGCGAGCAGGCCGGCGGGGACCGCCCGCGCGGGCACCGCTGGGCCGCCCAGCTCGACGCCCTCCCCGCCGCCCCCGCGCGCGGGACCGACCCGCGCGGCGGCGACCGCTTCTCGCACGCCACCGCCGTGCTGGAGCTGTACCGGCTGCTGCTGCGCCTGCCCGCCCTGGAACCCCTGGAGGAGCCGCGCCGCGAGCACGGCCCCACCGCCTCCCGCATGCTCACCCGCATCCGCGCGCTGCTCGCCAAGGCCGAGGCGACCGGCTACCCGGAGGAGGCGGAGGCCCTCAGCGCCAAGGCGCAGGAGCTGATGGCCCGGTACAGCGTCGACGAGGCGCTGCTCGCCGCCGGCGCCCCTTCCCCGGACGCGCCGGGAGCGTGCCGCATCGGGGTCGAGGCGCCGTACGAACAGGCCAAGGCGGTGCTGCTGGACGCGGTCGCCACCGCCAACCACTGCCGCGCGGTGTGGAACGAACCGCTCGGCTTCTCCACGGTGGTCGGCTTCGAGGCCGACCTGGAGGTGGTCGAGCTGCTCCACACCTCGCTGCTGGTGCAGGCCACGCACGCCATGACCAGGGCCGAGGCGGCCCAGCGAGCCGGTGGTCGCAGACGCACCAAGACCTTCCGGCAGTCGTTCCTCGCGGCCTACGCCCACCGGGTCGGCGACCGGCTCACGGCCGCCGCGGAGAGCCAGGTCACCCAGGACCTGCTGCCGGTGCTGGCCACGCGCGCGATAGCCGTCACCGACCGCACCGAGCGGATGTTCCCGCAGACCACGACGTCCCGGCTGCGCGGCGTGAGCGACGCGGCCGGCTGGACGGAGGGCGCACGGGCGGCGGACGAGGCCCAGGTCAGAGCCAGACCCCGGCTCGGCTGA	MTSEASTVERAFRGALYDDTDAGLDTGASLLAADPGADAELARRGEEFIAAAWQRGWQPADVVRLVRRELDETHVVLAARLIREQAGGDRPRGHRWAAQLDALPAAPARGTDPRGGDRFSHATAVLELYRLLLRLPALEPLEEPRREHGPTASRMLTRIRALLAKAEATGYPEEAEALSAKAQELMARYSVDEALLAAGAPSPDAPGACRIGVEAPYEQAKAVLLDAVATANHCRAVWNEPLGFSTVVGFEADLEVVELLHTSLLVQATHAMTRAEAAQRAGGRRRTKTFRQSFLAAYAHRVGDRLTAAAESQVTQDLLPVLATRAIAVTDRTERMFPQTTTSRLRGVSDAAGWTEGARAADEAQVRARPRLG	MSTIKIENLTFSYYGYVKPVFENVSFSFDTNWKTGLIGRNGIGKSTLFKLLLNQEVYKGKISKSVDFIKFPPNLSDTSKLGIELYRELISDEEEWKLFRELHLLKVDESLIYRKFETLSKGEQTKILLAILFTREDGFLLIDEPTNHLDMDGRKIVSEYLKNKKGFLLISHDRDFLDGCINHIISINRNSIDVQSGNFTSWYENKLMKDQFEISQNEKLRKDIKRLKEAARQSQIWSDKVENTKNGVKVSGVKPDKGHIGHQSAKMMKKSKNLENRQNKAIEEKQNLLKDIETKESLLLHPLHHHKNPLISVCDLSSYYGKKQILSNISFDIKQGDIVAIYGGNGSGKSTLIKILLGLNHEYSGDVKLASNLKISYVPQDTSNLTGSLNEYIHKQGVDETLCKTILRKLDFARELFEIDMKNYSDGQKKKVLIAVSLSKSAHIFIWDEPLNYLDVISRIQIEEIIKEANPTLIFVEHDKSFVEDIANKIIRL	75.81	gnl|BL_ORD_ID|1602|hsp_num:0	1748			1131	1368	lincomycin; clindamycin; pleuromutilin
